Molecular pathological classification of colorectal cancer—an update
Virchows Archiv · 2024-02 · 484 (2) · 273-285
DOI: 10.1007/s00428-024-03746-3 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Virchows Archiv, online erschienen am 06.02.2024. Verfasst von Philip D Dunne und 1 weiteren Autor:innen. Beteiligte Einrichtung: Patrick G. Johnston Centre for Cancer Research, Queens University Belfast, Belfast, Northern Ireland, BT8 7AE, UK. Hauptthemen laut MEDLINE: Colorectal Neoplasms. Die Arbeit wurde bisher 94-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Research UK.
Abstract (Originalsprache)
Colorectal cancer (CRC) has a broad range of molecular alterations with two major mechanisms of genomic instability (chromosomal instability and microsatellite instability) and has been subclassified into 4 consensus molecular subtypes (CMS) based on bulk RNA sequence data. Here, we update the molecular pathological classification of CRC with an overview of more recent bulk and single-cell RNA data analysis for development of transcriptional classifiers and risk stratification methods, taking into account the marked inter-tumoural and intra-tumoural heterogeneity of CRC. The importance of the stromal and immune components or tumour microenvironment (TME) to prognosis has emerged from these analyses. Attempts to remove the contribution of the tumour microenvironment and reveal neoplastic-specific transcriptional traits involved identification of the CRC intrinsic subtypes (CRIS). The use of immunohistochemistry and digital pathology to implement classification systems are evolving fields. Conventional adenoma versus serrated polyp pathway transcriptomic analysis and characterisation of canonical LGR5+ crypt base columnar stem cell versus ANXA1+ regenerative stem cell phenotypes emerged as key properties for improved understanding of transcriptional signals involved in molecular subclassification of colorectal cancers. Recently, classification by three pathway-derived subtypes (PDS1-3) has been developed, revealing a continuum of intrinsic biology associated with biological, stem cell, histopathological, and clinical attributes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Patrick G. Johnston Centre for Cancer Research, Queens University Belfast, Belfast, Northern Ireland, BT8 7AE, UK.
- Cancer Research UK Scotland Institute, Garscube Estate, Glasgow, G61 1QH, UK.
- Edinburgh Pathology & Cancer Research UK Scotland Centre, Institute of Genetics & Cancer, University of Edinburgh, Crewe Road, Edinburgh, EH4 2XR, UK. M.Arends@ed.ac.uk.
Förderung
- Cancer Research UK
Zitieren
APA
Dunne, P. D., & Arends, M. J. (2024). Molecular pathological classification of colorectal cancer—an update. Virchows Archiv, 484(2), 273-285. https://doi.org/10.1007/s00428-024-03746-3
Vancouver
Dunne PD, Arends MJ. Molecular pathological classification of colorectal cancer—an update. Virchows Archiv. 2024;484(2):273-285. doi:10.1007/s00428-024-03746-3
BibTeX
@article{Dunne2024,
author = {Dunne, Philip D and Arends, Mark J},
title = {Molecular pathological classification of colorectal cancer—an update},
journal = {Virchows Archiv},
year = {2024},
volume = {484},
number = {2},
pages = {273--285},
doi = {10.1007/s00428-024-03746-3}
}
EUVIMED